Insider holders · CIK 0001549595
Nurix Therapeutics, Inc. · NRIX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Gwenn HansenChief Scientific Officer | 117,227 | — | 117,227 | Sep 1, 2026 · 5:19 pm EDT | Form 4 |
| Hans van HouteChief Financial Officer | 40,166 | — | 40,166 | Aug 4, 2026 · 9:41 pm EDT | Form 4 |
| Christine RingChief Legal Officer | 9,110 | — | 9,110 | Sep 2, 2026 · 7:42 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.